In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004

Por Hecht, David W., Galang, Minerva A., Sambol, Susan P., Osmolski, James R., Johnson, Stuart, Gerding, Dale N.
Publicado em 2007

Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027

Por Wieczorkiewicz, Jeffrey T., Lopansri, Bert K., Cheknis, Adam, Osmolski, James R., Hecht, David W., Gerding, Dale N., Johnson, Stuart
Publicado no Antimicrob Agents Chemother (2015)

Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients

Por Kociolek, Larry K., Gerding, Dale N., Osmolski, James R., Patel, Sameer J., Snydman, David R., McDermott, Laura A., Hecht, David W.
Publicado no Antimicrob Agents Chemother (2016)

Kibdelomycin Is a Potent and Selective Agent against Toxigenic Clostridium difficile

Por Miesel, Lynn, Hecht, David W., Osmolski, James R., Gerding, Dale, Flattery, Amy, Li, Fangbiao, Lan, Jing, Lipari, Philip, Polishook, Jon D., Liang, Lianzhu, Liu, Jenny, Olsen, David B., Singh, Sheo B.
Publicado em 2014